WilmerHale Represents Medtronic in Senior Notes Offering

WilmerHale Represents Medtronic in Senior Notes Offering

Firm News

Related Solutions

Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.

On March 28, 2017, Medtronic plc's wholly owned subsidiaries, Medtronic, Inc. and Medtronic Global Holdings S.C.A., issued an aggregate principal amount of $2 billion of senior notes in concurrent SEC-registered underwritten public offerings. The net proceeds of the offerings will be used for general corporate purposes. Medtronic plc, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies—alleviating pain, restoring health and extending life for millions of people around the world. 

The WilmerHale deal team included Erika Robinson, John Sigel, Julie Hogan Rodgers, Chris Barnstable-Brown, Michael Shaw and Howell Ma.

Read Medtronic's formal press release for more information.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel